SCHEMBL24247689

SCHEMBL24247689

O=Cc1cnn2c(Br)c(OCc3ccccc3)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CCNB2 O95067 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CCNB3 Q8WWL7 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CCR5 P51681 2/20 0.40
▸ PTGER1 P34995 5/20 0.39
▸ USP28 Q96RU2 1/20 0.39
▸ USP25 Q9UHP3 1/20 0.39
▸ ERN1 O75460 2/20 0.39
▸ HTR1A P08908 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437909 0.77 PTGER1 (0.43) MAPK14L3MBTL1CCR5PTGER1CYP1A2
SCHEMBL20654240 0.75 CCR5 (0.40) MAPK14SMN1; SMN2RAB9AL3MBTL1HTT
SCHEMBL29690396 0.70 PTGDR2 (0.61) SMN1; SMN2NPC1MAPTRAB9ACCNB2
SCHEMBL82269 0.70 PTGDR2 (0.61) SMN1; SMN2NPC1MAPTRAB9ACCNB2
SCHEMBL29537861 0.68 CCNB2 (0.72) SMN1; SMN2NPC1MAPTRAB9AL3MBTL1
SCHEMBL433401 0.68 CCNB2 (0.72) SMN1; SMN2NPC1MAPTRAB9AL3MBTL1
SCHEMBL8305004 0.68 CCNB2 (0.58) MAPK14SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL31588911 0.68 MAPT (0.66) SMN1; SMN2NPC1MAPTRAB9AL3MBTL1
SCHEMBL16097909 0.68 CCNB2 (0.50) MAPK14SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL14318903 0.68 CYP1A2 (0.45) MAPK14SMN1; SMN2NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3954681-A1 SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Bristol-Myers Squibb Company (US) 2022-02-16 — — EP disclosed
Send feedback